Evolution of Nuclear Receptor Pseudogenes


Nuclear receptors (NRs) are transcription factors with deoxyribonucleic acid (DNA)‐binding and ligand‐receptor domains. When activated by ligands, they bind to the regulatory regions of target genes to regulate transcription. NR genes comprise relatively large gene families derived from a single metazoan parent gene through evolutionary duplication and divergence, which often produces duplication (unprocessed) pseudogenes. However, no NR duplication pseudogenes have been found in genomes examined to date. A small number of NR retropseudogenes (processed pseudogenes), and a single unitary pseudogene have been identified in the annotated human, chimpanzee, mouse and rat genomes. The unitary pseudogene (ψFXRβ) is exclusive to catarrhines and arose via mutational inactivation of the FXRβ gene, which is an active gene in murids. The human‐specific ψERRα+ pseudogene arose through duplication of a DNA segment containing the ψERRα–retropseudogene and is an example of a duplication retropseudogene. The murid ψRev‐erbβ and ψLRH1 pseudogenes are examples semiprocessed retropseudogenes.

Key concepts

  • There are relatively few nuclear receptor pseudogenes in vertebrate genomes.

  • Identified nuclear receptor genes consist of retropseudogenes and a single unitary pseudogene.

Keywords: nuclear receptor genes; pseudogenes; unitary pseudogenes; retropseudogenes


Bailey JA, Gu Z, Clark RA et al. (2002) Recent segmental duplications in the human genome. Science 297: 1003–1007.

Bertrand S, Brunet FG, Escriva H et al. (2004) Evolutionary genomics of nuclear receptors: from twenty‐five ancestral genes to derived endocrine systems. Molecular Biology and Evolution 21: 1923–1937.

Booth HA and Holland PW (2004) Eleven daughters of NANOG. Genomics 84: 229–238.

Escriva H, Safi R, Hänni C et al. (1997) Ligand binding was acquired during evolution of nuclear receptors. Proceedings of the National Academy of Sciences of the USA 94: 6803–6808.

Fairbanks DJ and Maughan PJ (2006) Evolution of the NANOG pseudogene family in the human and chimpanzee genomes. BMC Evolutionary Biology 6: 12.

Galili U (1993) Evolution and pathophysiology of the human natural anti‐alpha‐galactosyl IgG (anti‐Gal) antibody. Springer Seminars in Immunopathology 15: 155–171.

Galili U and Swanson K (1991) Gene sequences suggest inactivation of alpha‐1,3‐galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proceedings of the National Academy of Sciences of the USA 88: 7401–7404.

Laudet V (1997) Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. Journal of Molecular Endocrinology 19: 207–226.

Maglich JM, Sluder A, Guan X et al. (2001) Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biology 2. http://genomebiology.com/2001/2/8/RESEARCH/0029.

Nishikimi M and Yagi K (1991) Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. American Journal of Clinical Nutrition 54: 1203S–1208S.

Otte K, Kranz H, Kober I et al. (2003) Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Molecular and Cellular Biology 23: 864–872.

Robinson‐Rechavi M, Carpentier AS, Duffraisse M and Laudet V (2001) How many nuclear hormone receptors are there in the human genome? Trends in Genetics 17: 554–556.

Zhang Z, Burch PE, Cooney AJ et al. (2004) Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. Genome Research 14: 580–590.

Zhang Z, Carriero N and Gerstein M (2004) Comparative analysis of processed pseudogenes in the mouse and human genomes. Trends in Genetics 20: 62–67.

Zhang Z and Gerstein M (2003) The human genome has 49 cytochrome c pseudogenes, including a relic of a primordial gene that still functions in mouse. Gene 312: 61–72.

Zhang Z, Harrison P and Gerstein M (2002) Identification and analysis of over 2000 ribosomal protein pseudogenes in the human genome. Genome Research 12: 1466–1482.

Zhang Z, Harrison PM, Liu Y and Gerstein M (2003) Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome. Genome Research 13: 2541–2558.

Zhang ZD, Cayting P, Weinstock G and Gerstein M (2008) Analysis of nuclear receptor pseudogenes in vertebrates: how the silent tell their stories. Molecular Biology and Evolution 25: 131–143.

Zhu J, Sanborn JZ, Diekhans M et al. (2007) Comparative genomics search for losses of long‐established genes on the human lineage. PLoS Computational Biology 3(12): e247.

Further Reading

Balakirev ES and Ayala FJ (2003) Pseudogenes: are they “junk” or functional DNA? Annual Review of Genetics 37: 123–151.

Ding W, Lin L, Chen B and Dai J (2006) L1 elements, processed pseudogenes and retrogenes in mammalian genomes. IUBMB Life 58: 677–685.

Mighell AJ, Smith NR, Robinson PA and Markham AF (2000) Vertebrate pseudogenes. FEBS Letters 468: 109–114.

Zhang Z and Gerstein M (2004) Large‐scale analysis of pseudogenes in the human genome. Current Opinion in Genetics and Development 14: 328–335.

Zhou Q and Wang W (2008) On the origin and evolution of new genes: a genomic and experimental perspective. Journal of Genetics and Genomics 35: 639–648.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Fairbanks, Daniel J(Dec 2009) Evolution of Nuclear Receptor Pseudogenes. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0021760]